aTyr Pharma, Inc. (ATYR) vs Context Therapeutics Inc. (CNTX)
A side-by-side comparison of aTyr Pharma, Inc. and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CNTX
Context Therapeutics Inc.
$0.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ATYR vs CNTX
growth of $100 · dividends reinvested · last 2yATYR -83.2% (-59.1%/yr)CNTX -83.0% (-58.8%/yr)CNTX compounded faster over this window
ATYR CNTX
ATYR vs CNTX: by the numbers
- •CNTX is the larger company ($31M vs $28M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -32003.68% net margin).
Metrics side by side
Valuation
| Metric | ATYR | CNTX |
|---|---|---|
| P/S ratio | 149.66 | N/A |
| P/B ratio | 0.58 | 0.81 |
Profitability
| Metric | ATYR | CNTX |
|---|---|---|
| Gross margin | -717.37% | 0.00% |
| Operating margin | -40856.32% | 0.00% |
| Net margin | -32003.68% | 0.00% |
| ROE | -124.64% | -120.40% |
| ROIC | -109.29% | -126.84% |
Growth (annualized)
| Metric | ATYR | CNTX |
|---|---|---|
| Revenue CAGR (5Y) | -38.74% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.